Mesalazine was a new anti-ulcerous colitis drug.
美沙拉秦是一种新型抗溃疡性结肠炎药物。
Objective:To establish a method for quality control of Mesalazine enteric coated tablet.
目的：制定美沙拉嗪肠溶片的质量标准方法。
Objective: To investigate the stability of Mesalazine enter-coated tablets in different media.
目的：考察美沙拉嗪肠溶片在不同介质中的稳定性。
The synthetic technology and structural identification of anti-colitis drug mesalazine were reported.
报告了抗溃疡性结肠炎药美沙拉嗪的合成工艺及结构鉴定。
The synthetic technology and structural identification of anti - colitis drug mesalazine were reported.
报告了抗溃疡性结肠炎药美沙拉嗪的合成工艺及结构鉴定。
Conclusion: the method is simple and rapid, highly accurate and precise. It can control the quality of Mesalazine enteric coated tablet effectively.
结论：该方法准确可靠地进行定性、定量检测，能有效地控制制剂的质量。
HPLC method with electrochemical detection was established for the determination of the related substances-3-aminosalicylic acid, 2-aminophenol, 4-aminophenol, in mesalazine.
建立了高效液相色谱-电化学检测法测定美沙拉秦中有关物质3 -氨基水杨酸、2 -氨基苯酚和4 -氨基苯酚。
A HPLC method with electrochemical detection was established for the determination of the related substances-3-aminosalicylic acid, 2-aminophenol, 4-aminophenol, in mesalazine.
建立了高效液相色谱-电化学检测法测定美沙拉秦中有关物质3 -氨基水杨酸、2 -氨基苯酚和4 -氨基苯酚。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。
应用推荐